Show simple item record

dc.contributor.authorMakate, Marshall
dc.contributor.authorTait, Robert J
dc.contributor.authorWhetton, Steve
dc.contributor.authorScollo, Michelle
dc.contributor.authorBanks, Emily
dc.contributor.authorChapman, Janine
dc.contributor.authorDey, Tania
dc.contributor.authorHalim, Suraya Abdul
dc.contributor.authorMcEntee, Alice
dc.contributor.authorMuhktar, Aqif
dc.contributor.authorNorman, Richard
dc.contributor.authorPidd, Ken
dc.contributor.authorRoche, Ann
dc.contributor.authorAllsop, Steve
dc.date.accessioned2020-12-03T03:20:53Z
dc.date.available2020-12-03T03:20:53Z
dc.date.issued2019
dc.identifier.urihttp://hdl.handle.net/20.500.11937/81929
dc.description.abstract

In the twentieth century the tobacco epidemic killed an estimated 100 million people globally; in the twenty-first century it may kill one billion people (World Health Organization, 2008). The scientific evidence is clear: smoking causes significant adverse impacts on human health, and the main driver of continued consumption of tobacco by smokers is nicotine dependence. The purpose of this study was to update the estimated social costs of tobacco use in Australia given the changing prevalence of smoking, the length of time since the last national estimate was conducted (for 2004/05 (Collins and Lapsley, 2008)), and new evidence on tobacco caused conditions and costs of tobacco outside the health domain. The tobacco epidemic, although past its peak in Australia in terms of the prevalence of smoking, still extracts a considerable toll on the health and economic welfare of Australians. Given that there wereapproximately 2.4 million daily smokers at the time of the 2016 National Drug Strategy Household survey, this scale of harm could be expected to continue for some time if prevalence is not reduced considerably. From the international evidence, we identified 46 conditions wholly or partially caused by active smoking, three where it was protective and nine conditions caused by involuntary or secondhand smoking, with the harms from the caused conditions substantially outweighing the benefits from the prevented conditions. In twelve months (financial year 2015/16) there were 20,032 deaths from smoking-related causes in Australia and there were about 1.7 million smoking-related hospital inpatient episodes. Net tangible costs of smoking in 2015/16 were estimated to be $19.2 billion (range $16.3 billion to $24.0billion). The tangible costs in the calculation included the reduction in economic output due to premature mortality, hospital separation costs, other medical and social care costs including the cost of informal care provided by family and friends, costs arising from workplace absenteeism and presenteeism, and spending on tobacco by dependent smokers.In addition to the tangible costs of smoking, there are very significant intangible costs (e.g. the value of life lost, pain and suffering), both from premature mortality and from the lost quality of life of those experiencing smoking attributable ill-health. These intangible costs of smoking were estimated at $117.7 billion in 2015/16 (range $52.0 billion to $375.8 billion) with the total cost of smoking being $136.9 billion (range $68.3 billion to $399.7 billion) (see Summary Table 1 and Summary Figure 1). The most significant individual cost item within the tangible costs was the spending on tobacco by dependent smokers, which was estimated at $5.5 billion, followed by workplace costs ($5.0 billion) and the reduction in the present value of future economic output due to premature mortality ($3.4 billion). Other health costs were also estimated and these included outpatient treatment, specialist care and possible excess general practitioner visits. Further, we developed an estimate of informal carer costs, which is the unpaid care provided by family members to those with smoking-related conditions.

dc.titleIdentifying the Social Costs of Tobacco Use to Australia in 2015/16
dc.typeReport
dcterms.source.numberISBN 978-0-9942806-9-5
dcterms.source.titleIdentifying the Social Costs of Tobacco Use to Australia in 2015/16
dc.date.updated2020-12-03T03:20:53Z
curtin.departmentSchool of Public Health
curtin.accessStatusOpen access
curtin.facultyFaculty of Health Sciences
curtin.contributor.orcidMakate, Marshall [0000-0002-2005-2970]
curtin.contributor.orcidMakate, Marshall [0000-0002-2005-2970]
curtin.contributor.scopusauthoridMakate, Marshall [57191225058]
curtin.contributor.scopusauthoridMakate, Marshall [57191225058]


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record